Atypical primary headache responding to finger pressure: possible involvement of the vagus nerve? by unknown
J Headache Pain (2007) 8:60–62
DOI 10.1007/s10194-007-0355-6
Atypical primary headache responding to finger
pressure: possible involvement of the vagus
nerve?







Abstract We describe a case of
atypical primary headache strongly
responsive to prolonged pressure in
the anterior aspect of the neck. We
hypothesize that, at least in this
case, the trigemino-cervical system
and its connections with the vagus
nerve are involved.
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Cluster headache and chronic paroxysmal hemicrania
(CPH) are characterised by multiple attacks of severe,
strictly unilateral periorbital pain [1]. Nevertheless,
patients who have features typical of one primary
headache disorder and an additional feature typical of a
second disorder have been identified. Examples of this
include bilateral cluster headache, cluster headache with
aura and cyclic migraine, cluster-migraine and cluster-tic
disorder.
Headache patients may fail to exhibit a diagnostically
important feature of a primary headache disorder yet in all
other ways fulfil criteria for that disorder, for example
migrainous disorder and aura without headache.
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Finally, one disorder may be completely subsumed with-
in another: idiopathic stabbing headache may occur inde-
pendently but it is considered as a secondary manifestation
of migraine when it is associated with that disorder [2].
The whole spectrum of atypical primary headaches
was first described by Young [2].
Case report
GB, a 55-year-old female, came to our observation at the
Headache Unit of our Pain Center, in March 2005. She
had been suffering from headache at the age of 43. For ten
years she experienced daily headache attacks in periods of
four consecutive months, approximately once per year. In
the last year the headache had lost its yearly periodicity,
and at the time of observation GB had been complaining
of daily headaches for 15 months. Each attack lasted
60–120 min and occurred in the afternoon or evening,
with an average frequency of four attacks per day.
The pain was severe and squeezing in nature, associat-
ed with a right-eye ptosis, bilateral lacrimation and rhin-
orrhoea. It was initially located in the right mandibular
region, subsequently spreading to right eye, right anterior
region of her neck and the right nuchal region. Later on
the headache became bilateral and symmetric. The pain
was associated with nausea, vomiting and phonophoto-
phobia. During the attacks, the patient was restless, rock-
ing her head and body while standing or sitting in a dark,
quiet room.
The headache was triggered by lack of sleep and alco-
hol consumption.
Sumatriptan (subcutaneous and tablets 100 mg) did not
provide relief; NSAIDs were somewhat effective in
relieving her pain. GB reported that the most effective
pain control mechanism prior to referral was to apply dig-
ital pressure in the right anterior region of the neck. The
finger pressure is continuously and strongly applied dur-
ing all the attacks. This became a habit, which eventually
resulted in a cutaneous lesion in the stimulated area (Fig.
1). The picture shows an indurate inflammatory plaque
(approximate diameter 30 mm), with a central reactive
hyperkeratosis and irregular borders.
General and neurological examinations were normal.
MR imaging of the brain as well as extensive study of vas-
cular and craniomandibular systems and soft tissues of the
head and neck (MR angiography, TMJ X-rays and echo-
graphy) did not show any abnormalities.
A trial of indomethacin at a dose of 75 mg was fol-
lowed by a reduction in pain intensity from 7 to 5 on the
Numerical Rating Scale 0–10 (NRS; 0=no pain, 10=the
worst pain imaginable) and a reduction of frequency of
the attacks from 30 days/month to 20 days/month.
Because of the failure of previous treatments (verapamil,
valproate, atenolol, amitriptyline), after one month of
clinical observation we started topiramate monotherapy
75 mg/day. In the following three months GB experienced
a further strong reduction in pain intensity (daily NRS:
1–2/10) with the frequency of the headache attacks drop-
ping to 1 per month. The attacks were still responsive to
digital pressure of the neck. At 1-year follow-up visit GB
is clinically stable.
Discussion
This patient satisfied some of the International Headache
Society criteria [1] for chronic migraine and chronic clus-
ter headache. The striking temporal profile of episodic
short-duration headaches with the active phase lasting
four months, separated by approximately one year, the
presence of autonomic symptoms as well as the headache
frequency and circadian periodicity, are typical of cluster
headache. The presence of positive familial history,
phonophotophobia, nausea and vomiting is more typical
for the migraine diagnosis.
In the pathophysiology of all primary headaches the
brainstem trigeminocervical complex (TCC) seems to
play an important role. The TCC is a nociceptive structure
that exerts fundamental control over inputs from cervical
and trigeminal nociceptors [3].
Continuous vagal nerve stimulation (VNS) for 24 h in
rats produced significant antinociceptive effects in a
model of trigeminal pain [4]. The same efficacy was
observed in humans affected by chronic refractory
migraine and cluster headache [5]. VNS appears to inhib-
it activation of the TCC pain signalling sensory neurons
and decrease pain-related behaviour in rats. Vagal afferent
Fig. 1 Cutaneous lesion of the stimulated area in the anterior aspect
of the neck due to prolonged finger pressure
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stimulation predominantly inhibits sensory processing in
the TNC [6] and in the ventral posteromedial thalamic
nucleus [7].
In humans, on the cervical level the majority of senso-
ry vagus-nerve fibres are unmyelinated C-fibres that con-
vey sensory inputs from larynx, pharynx and visceral
organs. Evidence has recently been provided that stimula-
tion of these vagal fibres is able to decrease the activity of
peripheral and spinal nociceptive pathways via central and
peripheral mechanisms [8]. We hypothesise that the con-
tinuous pulsed finger pressure self-applied to the anterior
neck region could have provoked a mechanical stimula-
tion of the parasympathetic visceral fibres (e.g., vagus
nerve), with a comparable analgesic effect to that report-
ed in the above-mentioned observations and experimental
animal and human models of trigeminal pain [3, 5, 8].
Akerman and Goadsby demonstrate that topiramate
is capable of inhibiting neurogenic dural vasodilatation
in an animal model [9]. The results complement an elec-
trophysiological study that demonstrates inhibition of
trigeminocervical neurons activated by a nociceptive
stimulus at comparable doses. It is feasible that trigemi-
novascular inhibition plays a role in the antimigraine
effect of topiramate, although it is unlikely to be the full
explanation for its effects. The effect of topiramate
on TCC could play a major role in its antimigrainous
activity [10].
In summary we described an atypical primary
headache (cluster-migraine?) [2] responsive to anterior
finger pressure and to topiramate. A possible link between
these therapeutic approaches may be represented by the
TCC and its role in the primary headache pathogenesis.
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